Dupixent (dupilumab) now publicly reimbursed in Ontario and New Brunswick for the treatment of moderate to severe atopic dermatitis

25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...

Read more →

Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program

28 April 2021 - Additional provincial coverage expected to follow. ...

Read more →

Cystic fibrosis patients call on Premier Ford to provide immediate access to life saving treatments

18 March 2021 - Ontarians with cystic fibrosis made an emotional plea to Premier Ford this week in a video that ...

Read more →

Ontario makes commitment to funding CF drugs after approval process completed

19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...

Read more →

Ontario to begin vaccinations next week in Toronto, Ottawa

10 December 2020 - The first vaccines will go to health care workers at long-term care homes and other high-risk ...

Read more →

Radiopharmaceutical cancer treatment Lutathera now available to Ontario patients with midgut neuroendocrine tumours

8 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs. ...

Read more →

Pickering, Ont. mother living with cystic fibrosis approved for miracle drug: ‘I’m in shock’

24 January 2020 - A Pickering, Ont. mother fighting cystic fibrosis has received her late Christmas wish. ...

Read more →

Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)

18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...

Read more →

Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement

12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...

Read more →

Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy

13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Why Ontario parents could soon be paying more for prescription drugs

22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...

Read more →

Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday

26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...

Read more →

Ontario becomes first province to provide public funding of Tresiba for adults with diabetes mellitus

21 September 2018 - Manitoba to reimburse Tresiba following Ontario listing. ...

Read more →

Ontario NDP promise take-home cancer drug coverage ahead of election

30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...

Read more →